Effect of a free radical scavenger on nitric oxide release in microvessels

Vascular Pharmacology

Volumn 58, Issue 1-2, 2013, Pages 134-139

  Yamashita, Tsutomu ^a   Sakamoto, Kumi ^a   Yamanishi, Hiroshi ^a   Totani, Nagao ^a   Yamamoto, Junichiro ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; ENOS; INOS; Nitric oxide; Radical

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NORPHENAZONE; PLACEBO;

AORTA BIFURCATION; ARTICLE; CONTROLLED STUDY; ELECTROCHEMICAL ANALYSIS; ENDOTHELIUM CELL; ENZYME RELEASE; ILIAC ARTERY; IN VIVO STUDY; INFLAMMATION; MALE; MESENTERY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACETYLCHOLINE; ANIMALS; ANTIPYRINE; AORTA, ABDOMINAL; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; MALE; MICROCIRCULATION; MICROVESSELS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; UP-REGULATION;

EID: 84871713505     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.10.006     Document Type: Article

References (43)

1. Archer S. Measurement of nitric oxide in biological models. FASEB J. 1993, 7(2):349-360.
2. Arnal J.F. Nitric oxide and circulatory homeostasis. Ann. Cardiol. Angeiol. (Paris) 1997, 46(7):420-425.
3. Barros, K.V., R.A. Xavier, G.G. Abreu, C.A. Martinez, M.L. Ribeiro, A. Gambero, P.O. Carvalho, C.M. Nascimento, V.L. Silveira, Soybean and fish oil mixture increases IL-10, protects against DNA damage and decreases colonic inflammation in rats with dextran sulfate sodium (DSS) colitis. Lipids Health Dis. 9, 68.
4. Barry-Lane P.A., Patterson C., van der Merwe M., Hu Z., Holland S.M., Yeh E.T., Runge M.S. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 2001, 108(10):1513-1522.
5. Clapp B.R., Hingorani A.D., Kharbanda R.K., Mohamed-Ali V., Stephens J.W., Vallance P., MacAllister R.J. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc. Res. 2004, 64(1):172-178.
6. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993, 69(2):238-249.
7. Drapier J.C., Wietzerbin J., Hibbs J.B. Interferon-gamma and tumor necrosis factor induce the l-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 1988, 18(10):1587-1592.
8. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A.E. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001, 103(15):1955-1960.
9. Fleming I., Bauersachs J., Busse R. Paracrine functions of the coronary vascular endothelium. Mol. Cell. Biochem. 1996, 157(1-2):137-145.
10. Griendling K.K., Sorescu D., Lassegue B., Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 2000, 20(10):2175-2183.
11. Group E.A.I.S. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc. Dis. 2003, 15(3):222-229.
12. Gryglewski R.J., Chlopicki S., Uracz W., Marcinkiewicz E. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med. Sci. Monit. 2001, 7(1):1-16.
13. Jourd'heuil D. Increased nitric oxide-dependent nitrosylation of 4,5-diaminofluorescein by oxidants: implications for the measurement of intracellular nitric oxide. Free Radic. Biol. Med. 2002, 33(5):676-684.
14. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 1998, 70(13):2446-2453.
15. Lau A.T., Wang Y., Chiu J.F. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J. Cell. Biochem. 2008, 104(2):657-667.
16. Leikert J.F., Rathel T.R., Muller C., Vollmar A.M., Dirsch V.M. Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein. FEBS Lett. 2001, 506(2):131-134.
17. Luscher T.F. Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension?. Am. J. Hypertens. 1990, 3(4):317-330.
18. Malinski T., Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992, 358(6388):676-678.
19. McCarron R.M., Chen Y., Tomori T., Strasser A., Mechoulam R., Shohami E., Spatz M. Endothelial-mediated regulation of cerebral microcirculation. J. Physiol. Pharmacol. 2006, 57(Suppl. 11):133-144.
20. Meisinger C., Baumert J., Khuseyinova N., Loewel H., Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005, 112(5):651-657.
21. Moncada S., Higgs E.A. Nitric oxide and the vascular endothelium. Handb. Exp. Pharmacol. 2006, (176 Pt 1):213-254.
22. Ogita H., Liao J. Endothelial function and oxidative stress. Endothelium 2004, 11(2):123-132.
23. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98(3):694-702.
24. Ozono R., Brydun A., Watari Y., Yamamoto Y., Ohshima T. Assessment of oxidative stress in patients with atherosclerosis focusing on heme oxygenase. Rinsho Byori 2007, 55(8):758-763.
25. Patel V.H., Brack K.E., Coote J.H., Ng G.A. A novel method of measuring nitric-oxide-dependent fluorescence using 4,5-diaminofluorescein (DAF-2) in the isolated Langendorff-perfused rabbit heart. Pflugers Arch. 2008, 456(3):635-645.
26. Rao Y.M., Chaudhury A., Goyal R.K. Active and inactive pools of nNOS in the nerve terminals in mouse gut: implications for nitrergic neurotransmission. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294(3):G627-G634.
27. Ravalli S., Albala A., Ming M., Szabolcs M., Barbone A., Michler R.E., Cannon P.J. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation 1998, 97(23):2338-2345.
28. Rudic R.D., Sessa W.C. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am. J. Hum. Genet. 1999, 64(3):673-677.
29. Samdani A.F., Dawson T.M., Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke 1997, 28(6):1283-1288.
30. Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nihon Yakurigaku Zasshi 2002, 119(5):301-308.
31. Teraki Y., Moriya N., Shiohara T. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. Am. J. Pathol. 1994, 145(3):550-560.
32. Toda N., Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol. Rev. 2003, 55(2):271-324.
33. Tomioka H., Hattori Y., Fukao M., Sato A., Liu M., Sakuma I., Kitabatake A., Kanno M. Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: importance of processes mediating precontractions. J. Vasc. Res. 1999, 36(4):311-320.
34. Tracey W.R., Linden J., Peach M.J., Johns R.A. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF. J. Pharmacol. Exp. Ther. 1990, 252(3):922-928.
35. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 1990, 323(1):27-36.
36. Wang P., Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 1996, 271(46):29223-29230.
37. Watanabe T., Yuki S., Egawa M., Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 1994, 268(3):1597-1604.
38. Xi H., Akishita M., Nagai K., Yu W., Hasegawa H., Eto M., Kozaki K., Toba K. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis 2007, 191(2):281-289.
39. Yamashita T., Shoge M., Oda E., Yamamoto Y., Giddings J.C., Kashiwagi S., Suematsu M., Yamamoto J. The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo. Platelets 2006, 17(3):201-206.
40. Ye X., Kim W.S., Rubakhin S.S., Sweedler J.V. Measurement of nitric oxide by 4,5-diaminofluorescein without interferences. Analyst 2004, 129(12):1200-1205.
41. Yoneda Y., Uehara T., Yamasaki H., Kita Y., Tabuchi M., Mori E. Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 2003, 34(3):718-724.
42. Zhang F., Xu S., Iadecola C. Role of nitric oxide and acetylcholine in neocortical hyperemia elicited by basal forebrain stimulation: evidence for an involvement of endothelial nitric oxide. Neuroscience 1995, 69(4):1195-1204.
43. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005, 36(10):2220-2225.